Randomised Controlled TrialtcVNSn = 21

Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: A double-blind, randomized, sham-controlled pilot study

Gazi AH, Harrison AB, Lambert TP, Obideen M, Alavi P, Murrah N, Shallenberger L, Driggers EG, Ortega RA, Washington BP, et al.

Brain Stimulation · 2022

Key finding

Active tcVNS during opioid cue exposure significantly reduced subjective withdrawal, pain, distress, and heart rate versus sham, though craving did not differ significantly.

Condition
Addiction
Stimulation
tcVNS
Evidence tier
Randomised Controlled Trial
Participants
21
View on DOI

Cite this study

Gazi, A. H., Harrison, A. B., Lambert, T. P., Obideen, M., Alavi, P., Murrah, N., Shallenberger, L., Driggers, E. G., Ortega, R. A., Washington, B. P., Walton, K. M., Welsh, J. W., Vaccarino, V., Shah, A. J., Tang, Y. L., Gupta, R., Back, S. E., Inan, O. T., & Bremner, J. D. (2022). Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: A double-blind, randomized, sham-controlled pilot study. Brain Stimulation, 15(5), 1206-1214. https://doi.org/10.1016/j.brs.2022.08.017

Related studies in Addiction

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.